The Insitut Galli-Valerio in Lausanne, Switzerland, has chosen a Freedom EVO® platform to fully automate all ELISAs for the Swiss authorities' ambitious program to eradicate bovine virus diarrhea virus (BVDV), which can cause mucosal disease in cattle.
